Type |
Details |
Score |
Allele |
Name: |
dedicator of cyto-kinesis 2; mutation 10, Bruce Beutler |
Allele Type: |
Chemically induced (ENU) |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, chemically induced mutation, coisogenic |
|
•
•
•
•
•
|
Allele |
Name: |
dedicator of cyto-kinesis 2; mutation 11, Bruce Beutler |
Allele Type: |
Chemically induced (ENU) |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Strain |
Attribute String: |
chemically induced mutation, mutant strain, coisogenic |
|
•
•
•
•
•
|
Allele |
Name: |
dedicator of cyto-kinesis 2; mutation 12, Bruce Beutler |
Allele Type: |
Chemically induced (ENU) |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, chemically induced mutation, coisogenic |
|
•
•
•
•
•
|
Allele |
Name: |
dedicator of cyto-kinesis 2; mutation 8, Bruce Beutler |
Allele Type: |
Chemically induced (ENU) |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, chemically induced mutation, coisogenic |
|
•
•
•
•
•
|
Allele |
Name: |
dedicator of cyto-kinesis 2; mutation 15, Bruce Beutler |
Allele Type: |
Chemically induced (ENU) |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, coisogenic, chemically induced mutation |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dock2/Dock2 |
Background: |
C57BL/6J-Dock2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dock2/Dock2 |
Background: |
C57BL/6J-Dock2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dock2/Dock2 |
Background: |
C57BL/6J-Dock2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dock2/Dock2 |
Background: |
C57BL/6J-Dock2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dock2/Dock2 |
Background: |
C57BL/6J-Dock2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dock2/Dock2 |
Background: |
C57BL/6J-Dock2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dock2/Dock2 |
Background: |
C57BL/6J-Dock2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dock2/Dock2 |
Background: |
C57BL/6J-Dock2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dock2/Dock2 |
Background: |
C57BL/6J-Dock2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
DOCK family members are evolutionarily conserved guanine nucleotide exchange factors (GEFs) for Rho-family GTPases []. DOCK proteins are required during several cellular processes, such as cell motility and phagocytosis. The N-terminal SH3 domain of the DOCK proteins functions as an inhibitor of GEF, which can be relieved upon its binding to the ELMO1-3 adaptor proteins, after their binding to active RhoG at the plasma membrane [, ]. DOCK family proteins are categorised into four subfamilies based on their sequence homology: DOCK-A subfamily (DOCK1/180, 2, 5), DOCK-B subfamily (DOCK3, 4), DOCK-C subfamily (DOCK6, 7, 8), DOCK-D subfamily (DOCK9, 10, 11) []. This entry represents DOCK2 (dedicator of cytokinesis 2). DOCK2 is involved in cytoskeletal rearrangements required for lymphocyte migration in response of chemokines. It activates RAC1 and RAC2, but not CDC42, by functioning as a guanine nucleotide exchange factor (GEF), which exchanges bound GDP for free GTP. It may also participate in IL2 transcriptional activation via the activation of RAC2 []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Komander D |
Year: |
2008 |
Journal: |
Mol Biol Cell |
Title: |
An alpha-helical extension of the ELMO1 pleckstrin homology domain mediates direct interaction to DOCK180 and is critical in Rac signaling. |
Volume: |
19 |
Issue: |
11 |
Pages: |
4837-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang J |
Year: |
2014 |
Journal: |
Int J Gynecol Cancer |
Title: |
Elmo1 helps dock180 to regulate Rac1 activity and cell migration of ovarian cancer. |
Volume: |
24 |
Issue: |
5 |
Pages: |
844-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Capala ME |
Year: |
2014 |
Journal: |
PLoS One |
Title: |
ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML. |
Volume: |
9 |
Issue: |
10 |
Pages: |
e111568 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li H |
Year: |
2013 |
Journal: |
Nat Commun |
Title: |
Association between Gαi2 and ELMO1/Dock180 connects chemokine signalling with Rac activation and metastasis. |
Volume: |
4 |
|
Pages: |
1706 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This entry represents engulfment and cell motility protein 1 (ELMO1) from vertebrates. ELMO1 is a scaffolding component of the Elmo-Dock complex. It interacts with DOCK180, which is essential for activation of Rac GTPase-dependent biological processes. Its C-terminal pleckstrin homology (PH) domain mediates direct interaction to DOCK180 and is critical in Rac signalling []. ELMO1 also interacts with DOCK2 and plays a role in controlling DOCK2 levels and DOCK2-dependent T cell migration in primary lymphocytes [, ]. ELMO1 has been linked to invasive phenotype of cancer cells [, , ].ELMO 1-3 are orthologues of the Caenorhabditis elegans ced-12, which is required for the engulfment of dying cells and cell migration []. They are cytoplasmic adaptor proteins that interact with DOCK family guanine nucleotide exchange factors (GEFs) to promote activation of the small GTPase Rac []. ELMO proteins interact with the SH3-domain of DOCKs via an SH3-binding site to enhance the GEF activity of DOCKs. Regulatory GTPases in the Ras superfamily employ a cycle of alternating GTP binding and hydrolysis, controlled by GEFs and GTPase-activating proteins (GAPs), as essential features of their actions in cells [, ]. |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
86
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
295
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Tajiri H |
Year: |
2017 |
Journal: |
Cell Rep |
Title: |
Targeting Ras-Driven Cancer Cell Survival and Invasion through Selective Inhibition of DOCK1. |
Volume: |
19 |
Issue: |
5 |
Pages: |
969-980 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
193
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Yan D |
Year: |
2006 |
Journal: |
J Mol Biol |
Title: |
An isoform of GTPase regulator DOCK4 localizes to the stereocilia in the inner ear and binds to harmonin (USH1C). |
Volume: |
357 |
Issue: |
3 |
Pages: |
755-64 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pierini R |
Year: |
2013 |
Journal: |
J Immunol |
Title: |
ASC controls IFN-γ levels in an IL-18-dependent manner in caspase-1-deficient mice infected with Francisella novicida. |
Volume: |
191 |
Issue: |
7 |
Pages: |
3847-57 |
|
•
•
•
•
•
|
Publication |
First Author: |
Morino K |
Year: |
2023 |
Journal: |
Front Immunol |
Title: |
Cholesterol sulfate limits neutrophil recruitment and gut inflammation during mucosal injury. |
Volume: |
14 |
|
Pages: |
1131146 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gumienny TL |
Year: |
2001 |
Journal: |
Cell |
Title: |
CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. |
Volume: |
107 |
Issue: |
1 |
Pages: |
27-41 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yasuda K |
Year: |
2014 |
Journal: |
PLoS One |
Title: |
Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2. |
Volume: |
9 |
Issue: |
7 |
Pages: |
e103478 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kulkarni K |
Year: |
2011 |
Journal: |
J Biol Chem |
Title: |
Multiple factors confer specific Cdc42 and Rac protein activation by dedicator of cytokinesis (DOCK) nucleotide exchange factors. |
Volume: |
286 |
Issue: |
28 |
Pages: |
25341-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
Thackray LB |
Year: |
2014 |
Journal: |
J Virol |
Title: |
Interferon regulatory factor 5-dependent immune responses in the draining lymph node protect against West Nile virus infection. |
Volume: |
88 |
Issue: |
19 |
Pages: |
11007-21 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
727
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
741
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Bowzard JB |
Year: |
2007 |
Journal: |
J Biol Chem |
Title: |
ELMOD2 is an Arl2 GTPase-activating protein that also acts on Arfs. |
Volume: |
282 |
Issue: |
24 |
Pages: |
17568-80 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1567
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
732
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1175
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Lu M |
Year: |
2005 |
Journal: |
Curr Biol |
Title: |
A Steric-inhibition model for regulation of nucleotide exchange via the Dock180 family of GEFs. |
Volume: |
15 |
Issue: |
4 |
Pages: |
371-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gadea G |
Year: |
2014 |
Journal: |
Eur J Cell Biol |
Title: |
Dock-family exchange factors in cell migration and disease. |
Volume: |
93 |
Issue: |
10-12 |
Pages: |
466-77 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1828
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Côté JF |
Year: |
2002 |
Journal: |
J Cell Sci |
Title: |
Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity. |
Volume: |
115 |
Issue: |
Pt 24 |
Pages: |
4901-13 |
|
•
•
•
•
•
|